Tower Research Capital (TRC)’s Enlivex Ltd ENLV Stock Holding History

Tower Research Capital (TRC)’s Portfolio ENLV Stock Details ENLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.68K	Buy	192 +43	+29%	+$681	﹤0.01%	4436
2025 Q4	$1.57K	Buy	+149	New	+$2.22K	﹤0.01%	4675
2022 Q1	–	Sell	-4	Closed	–	–	6192
2021 Q4	$0	Sell	4 -8	-67%	-$942	﹤0.01%	6235
2021 Q3	$2K	Buy	+12	New	+$1.76K	﹤0.01%	5252
2021 Q2	–	Sell	-166	Closed	-$28K	–	5553
2021 Q1	$28K	Buy	+166	New	+$34.2K	﹤0.01%	3605
2016 Q4	–	Hold	0	–	–	–	3950
2016 Q3	–	Hold	0	–	–	–	3818
2016 Q2	–	Hold	0	–	–	–	4543
2016 Q1	–	Sell	-3	Closed	-$5.34K	–	3672
2015 Q4	$6K	Buy	+3	New	+$8.46K	﹤0.01%	2752
2015 Q3	–	Hold	0	–	–	–	4185
2015 Q2	–	Sell	-1	Closed	-$3K	–	4523
2015 Q1	$3K	Hold	1	–	–	﹤0.01%	3550
2014 Q4	$6K	Hold	1	–	–	﹤0.01%	2578
2014 Q3	$2K	Buy	+1	New	+$4.89K	﹤0.01%	3794

Other funds holding ENLV

Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

PCM

Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Tower Research Capital (TRC)'s ENLV Position: Q1 2026 in Review

Tower Research Capital (TRC) increased its Enlivex Ltd (ENLV) stake by 29% in Q1 2026, buying an estimated $681 and bringing the position to 192 shares worth $2.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4436.

Tower Research Capital (TRC) first reported a position in ENLV in Q3 2014 and has held it in 9 quarters since. The position peaked at $28K in Q1 2021. 34 funds tracked by Wall St. Rank hold ENLV as of Q1 2026.

Tower Research Capital (TRC) held 192 shares of Enlivex Ltd worth $2.68K as of Q1 2026.
Tower Research Capital (TRC) bought 43 Enlivex Ltd shares in Q1 2026, an estimated $681.
Enlivex Ltd made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4436 holding.
Tower Research Capital (TRC) first reported a position in Enlivex Ltd in Q3 2014 and has held it in 9 quarters since.
Tower Research Capital (TRC)'s Enlivex Ltd position peaked at $28K in Q1 2021.
34 funds tracked by Wall St. Rank held Enlivex Ltd as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.